Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Photosystem II
100%
Therapeutic Potential
100%
Current Treatment
100%
Emerging Treatments
100%
Enzyme Replacement Therapy
50%
Gene Therapy
25%
Hematopoietic Stem Cell Transplantation
25%
Substrate Reduction Therapy
25%
Chaperone Therapy
25%
Early Diagnosis
12%
Glycosaminoglycans
12%
Clinical Trials
12%
Newborn Screening
12%
Natural History
12%
Avascular
12%
Cartilage
12%
Diagnosis Treatment
12%
Blood-brain Barrier
12%
Early Treatment
12%
Fusion Protein
12%
Potential Impact
12%
Cornea
12%
Inborn Errors of Metabolism
12%
Therapeutic Efficacy
12%
Treatment Impact
12%
Heart Valve
12%
Blood-brain Barrier Penetration
12%
Barrier Treatment
12%
Clinical Endpoints
12%
Intrathecal
12%
Clinical Biomarkers
12%
Major Challenges
12%
Accessible Treatment
12%
Estimated Incidence
12%
INIS
therapy
100%
enzymes
62%
reduction
25%
substrates
25%
stem cells
25%
gene therapy
25%
blood-brain barrier
25%
reviews
12%
tissues
12%
birth
12%
inclusions
12%
patients
12%
proteins
12%
metabolism
12%
diseases
12%
cartilage
12%
screening
12%
morbidity
12%
errors
12%
clinical trials
12%
newborns
12%
biological markers
12%
organs
12%
valves
12%
cornea
12%
Pharmacology, Toxicology and Pharmaceutical Science
Mucopolysaccharidosis
100%
Enzymes
62%
Replacement Therapy
50%
Blood-Brain Barrier
25%
Clinical Trial
12%
Glycosaminoglycan
12%
Biological Marker
12%
Morbidity
12%
Inborn Error of Metabolism
12%
Intrathecal
12%
Chimeric Protein
12%
Diseases
12%
Biochemistry, Genetics and Molecular Biology
Mucopolysaccharidosis
100%
Enzyme
62%
Gene Therapy
25%
Hematopoietic Stem Cell Transplantation
25%
Blood Brain Barrier
25%
Clinical Trial
12%
Morbidity
12%
Newborn Screening
12%
Inborn Error of Metabolism
12%
Glycosaminoglycan
12%
Chimeric Protein
12%
Deficiency
12%